Evidence map›Paper›PMID 33655452›Full record

ArticleAnnals of intensive care2021

Continuous positive airway pressure for respiratory support during COVID-19 pandemic: a frugal approach from bench to bedside.

Guillaume Carteaux, Manuella Pons, François Morin, Samuel Tuffet, Arnaud Lesimple, Bilal Badat, Anne-Fleur Haudebourg, François Perier, Yvon Deplante, Constance Guillaud and 19 more

Open access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 7 institutions in 2 countries.

Guillaume CarteauxAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor-Albert Chenevier, Service de Médecine Intensive Réanimation, 51, Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France. guillaume.carteaux@aphp.fr.ORCID http://orcid.org/0000-0003-1175-8821
Manuella Pons *Faculté de Santé, Groupe de Recherche Clinique CARMAS, Université Paris Est-Créteil, 94010, Créteil, France.
François Morin *Département de Médecine d'Urgence, Faculté de Santé, Centre Hospitalier Universitaire d'Angers, Université d'Angers, Angers, France.
Samuel TuffetAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor-Albert Chenevier, Service de Médecine Intensive Réanimation, 51, Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France.
Arnaud LesimpleCNRS, INSERM 1083, MITOVASC, Université d'Angers, Angers, France.
Bilal BadatLaboratoire Med2Lab ALMS, Antony, France.
Anne-Fleur HaudebourgAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor-Albert Chenevier, Service de Médecine Intensive Réanimation, 51, Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France.
François PerierAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor-Albert Chenevier, Service de Médecine Intensive Réanimation, 51, Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France.
Yvon DeplanteFaculté de Santé, Groupe de Recherche Clinique CARMAS, Université Paris Est-Créteil, 94010, Créteil, France.
Constance GuillaudDépartement d'Aval des Urgences, Assistance Publique-Hôpitaux de Paris, CHU Henri Mondor, 94010, Créteil, France.
Frédéric SchlemmerINSERM U955, Institut Mondor de Recherche Biomédicale, 94010, Créteil, France.
Elena FoisAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor, Unité des Maladies Génétiques du Globule Rouge, 94010, Créteil, France.
Nicolas MongardonAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor, Service d'Anesthésie-Réanimation Chirurgicale, 94010, Créteil, France.
Mehdi KhellafEmergency Department, Assistance Publique-Hôpitaux de Paris, CHU Henri Mondor, 94010, Créteil, France.
Karim JaffalAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor, Service d'immunologie Clinique Et Maladies Infectieuses, 94010, Créteil, France.
Camille DeguillardDepartment of Cardiovascular Medicine, Assistance Publique-Hôpitaux de Paris, CHU Henri Mondor, 94010, Créteil, France.
Philippe GrimbertAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor, Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare « Syndrome Néphrotique Idiopathique », 94010, Créteil, France.
Raphaëlle HuguetDepartment of Cardiovascular Medicine, Assistance Publique-Hôpitaux de Paris, CHU Henri Mondor, 94010, Créteil, France.
Keyvan RazaziAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor-Albert Chenevier, Service de Médecine Intensive Réanimation, 51, Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France.
Nicolas de ProstAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor-Albert Chenevier, Service de Médecine Intensive Réanimation, 51, Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France.
François TemplierDépartement de Médecine d'Urgence, Faculté de Santé, Centre Hospitalier Universitaire d'Angers, Université d'Angers, Angers, France.
François BeloncleCNRS, INSERM 1083, MITOVASC, Université d'Angers, Angers, France.
Alain MercatCNRS, INSERM 1083, MITOVASC, Université d'Angers, Angers, France.
Laurent BrochardKeenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Canada.
Vincent AudardAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor, Service de Néphrologie et Transplantation, Centre de Référence Maladie Rare « Syndrome Néphrotique Idiopathique », 94010, Créteil, France.
Pascal LimINSERM U955, Institut Mondor de Recherche Biomédicale, 94010, Créteil, France.
Jean-Christophe RichardDépartement de Médecine Intensive-Réanimation et Médecine Hyperbare, Faculté de Santé, Centre Hospitalier Universitaire d'Angers, Vent' Lab, Université d'Angers, Angers, France.
Dominique SavaryDépartement de Médecine d'Urgence, Faculté de Santé, Centre Hospitalier Universitaire d'Angers, Université d'Angers, Angers, France.
Armand Mekontso DessapAssistance Publique-Hôpitaux de Paris, CHU Henri Mondor-Albert Chenevier, Service de Médecine Intensive Réanimation, 51, Avenue du Maréchal de Lattre de Tassigny, 94010, Créteil Cedex, France.
Inserm · FRCentre Hospitalier Universitaire Henri-Mondor · FRCentre National de la Recherche Scientifique · FRCentre Hospitalier Universitaire d'Angers · FRUniversité Paris-Est Créteil · FRInstitut de Recherche en Santé, Environnement et Travail · FRSt. Michael's Hospital · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe describe a frugal approach (focusing on needs, performance, and costs) to manage a massive influx of COVID-19 patients with acute hypoxemic respiratory failure (AHRF) using the Boussignac valve protected by a filter ("Filter Frugal CPAP", FF-CPAP) in and out the ICU.

methods(1) A bench study measured the impact of two filters with different mechanical properties on CPAP performances, and pressures were also measured in patients. (2) Non-ICU healthcare staff working in COVID-19 intermediate care units were trained with a video tutorial posted on a massive open online course. (3) A clinical study assessed the feasibility and safety of using FF-CPAP to maintain oxygenation and manage patients out of the ICU during a massive outbreak.

resultsBench assessments showed that adding a filter did not affect the effective pressure delivered to the patient. The resistive load induced by the filter variably increased the simulated patient's work of breathing (6-34%) needed to sustain the tidal volume, depending on the filter's resistance, respiratory mechanics and basal inspiratory effort. In patients, FF-CPAP achieved pressures similar to those obtained on the bench. The massive training tool provided precious information on the use of Boussignac FF-CPAP on COVID-19 patients. Then 85 COVID-19 patients with ICU admission criteria over a 1-month period were studied upon FF-CPAP initiation for AHRF. FF-CPAP significantly decreased respiratory rate and increased SpO

conclusionAdding a filter to the Boussignac valve does not affect the delivered pressure but may variably increase the resistive load depending on the filter used. Clinical assessment suggests that FF-CPAP is a frugal solution to provide a ventilatory support and improve oxygenation to numerous patients suffering from AHRF in the context of a massive outbreak.

Indexed as

Acute hypoxemic respiratory failureContinuous positive airway pressureCOVID-19Frugal innovation

Identifiers

PMID33655452
PMCPMC7924341
OpenAlexW3135183914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.